Eli Lilly and Co

LLY

Company Profile

  • Business description

    Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

  • Contact

    Lilly Corporate Center
    IndianapolisIN46285
    USA

    T: +1 317 276-2000

    E: [email protected]

    https://www.lilly.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2025

    Employees

    47,000

Stocks News & Analysis

stocks

Microsoft earnings: Strong, including Azure, but overall guidance is in line

We think Microsoft stock is moderately undervalued.
stocks

After earnings, is Tesla stock a buy, a sell, or fairly valued?

Q3 earnings reflected sequential improvement driven by record auto deliveries and energy storage deployments.
stocks

3 cheap fully franked stocks

Well priced Aussie shares that offer a tax rebate.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,178.0028.70-0.31%
CAC 408,157.2943.59-0.53%
DAX 4024,118.895.32-0.02%
Dow JONES (US)47,522.12109.88-0.23%
FTSE 1009,760.063.920.04%
HKSE25,999.70282.99-1.08%
NASDAQ23,581.14377.33-1.57%
Nikkei 22552,244.44918.831.79%
NZX 50 Index13,548.3289.030.66%
S&P 5006,822.3468.25-0.99%
S&P/ASX 2008,881.9031.30-0.35%
SSE Composite Index3,955.9230.98-0.78%

Market Movers